Magnendo
Summary active Updated Jul 26, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
Magnendo is a Newton, Massachusetts-based MIT spinout developing magnetic robotic navigation technology for neuro-endovascular intervention 123. Founded by Yoonho Kim, Ph.D., the company is building a robotic system that combines magnetically steerable guidewires with robotic control, advanced medical imaging, and intelligent navigation software to improve endovascular access 12. The platform is designed to help physicians navigate complex vascular anatomy more quickly and reliably while remaining compatible with existing clinical workflows and commercially available devices 12.
On 2026-07-24 Magnendo announced the closing of an $18M Series A led by Penumbra, Inc., with participation from a syndicate of new and existing institutional investors 123. The financing will support productization of Magnendo’s robotic platform and preparation for first-in-human clinical studies 12. The technology addresses a significant bottleneck in stroke treatment: while mechanical thrombectomy has transformed treatment of acute ischemic stroke, navigating from the vascular access site to the clot through complex patient anatomy contributes to prolonged procedure times and poorer outcomes 12.
Disclaimer: This is a lean profile built from initial round coverage and may be expanded as more information becomes available.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-07-24 | Series A | $18M | Penumbra | Undisclosed syndicate 123 |
What Investors Say
Magnendo has developed an elegant and pragmatic approach to one of the most challenging aspects of endovascular intervention.
— Shruthi Narayan, President of Penumbra, in the Series A announcement, July 24, 2026 12
What Founders Say
Our mission is to redefine endovascular access through magnetic robotic navigation, enabling physicians to reach the treatment site faster, more reliably, and with greater consistency.
— Yoonho Kim, Founder & CEO of Magnendo, in the Series A announcement, July 24, 2026 12
Sources
-
BioSpace, “Magnendo Secures $18M Series A Financing to Transform Endovascular Access for Stroke Intervention,” July 24, 2026. Accessed July 2026. https://www.biospace.com/press-releases/magnendo-secures-18m-series-a-financing-to-transform-endovascular-access-for-stroke-intervention↩↩↩↩↩↩↩↩↩
-
The Manila Times / GlobeNewswire, “Magnendo Secures $18M Series A Financing to Transform Endovascular Access for Stroke Intervention,” July 24, 2026. Accessed July 2026. https://www.manilatimes.net/2026/07/24/tmt-newswire/globenewswire/magnendo-secures-18m-series-a-financing-to-transform-endovascular-access-for-stroke-intervention/2391063↩↩↩↩↩↩↩↩↩
-
MassDevice, “Magnendo raises $18M Series A led by Penumbra to support magnetic endovascular robotic tech,” July 2026. Accessed July 2026. https://www.massdevice.com/magnendo-18m-magnetic-robotic-tech-penumbra/↩↩↩